Tizanidine Tablet
Product Images NDC 63629-2371

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-2371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
The text describes the improvement in Ashworth Score with dosage mentioned in mg over a certain period of time in a study. It mentions the end of titration and maintenance with the last observation carried forward as the endpoint.*
FDA Label Image

Label (Lbl636292371)

Label (Lbl636292371)
This text describes medication called "Tizanidine Tablets, USP" containing 4.567 mg tizanidine HCI, equivalent to 4 mg of tizanidine base. It instructs to keep the medication out of reach of children, store it at room temperature, and dispense it in a child-resistant container. The NDC number for this medication is 63629-2371-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.